ATLANTA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS) complied with federal securities laws. On November 4, 2024, Hindenburg Research published a report alleging that “PACS’ ‘turnaround’ strategy largely boils down to systematically scamming taxpayer-funded healthcare programs.” Following this news, the price of the Company’s stock dropped.  If you purchased PACS stock and suffered a loss on that investment, you are e ...